Cabaletta Bio Statistics
NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.9361-0.0739 (-7.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cabaletta Bio by the numbers
Cabaletta Bio has a market capitalization of $201.9 million based on 215.72M shares outstanding. With trailing EPS of $-1.33, Cabaletta Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.8% below its 50-day average and 66.0% below its 200-day average.
Average daily trading volume is 5.15M shares, or about $4.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CABA valuation vs. peer median
| Metric | CABA | Peer median | Difference |
|---|---|---|---|
| Market cap | $201.94M | $203.41M | -1% |
| Avg. volume | 5.15M | 775.98K | +564% |
Peer median across 8 companies: LCTX, IPSC, ARTV, ALLO, IKT, SCTX, CGEN, AUTL.
Valuation
- Market cap
- $201.94M
- EPS (TTM)
- $-1.33
- Shares outstanding
- 215.72M
Price and trading
- Previous close
- 1.01
- Open
- 0.99
- Day range
- 0.93 – 1.03
- 52-week range
- 0.93 – 4.23
- 52-week change
- -55.00%
- Beta
- —
- Volume
- 3.73M
- Average volume
- 5.15M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 201.94M
- Forward Pe
- -0.84
- Eps
- -1.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.23
- Week52 Low
- 0.93
- Avg Volume
- 5.15M
- Shares Outstanding
- 215.72M
- Ma50
- 1.73
- Ma200
- 2.76
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -77.87%
- Pct From52w Low
- 0.66%